Janika Viereck

About

Work

Cardior Pharmaceuticals GmbH
|

Head of Research and Development

Germany

Publications

Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.

Published by

European journal of heart failure

Summary

journal-article

Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome.

Published by

JACC. Basic to translational science

Summary

journal-article

AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.

Published by

Molecular therapy : the journal of the American Society of Gene Therapy

Summary

journal-article

ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.

Published by

Circulation. Heart failure

Summary

journal-article

AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.

Published by

Journal of the American College of Cardiology

Summary

journal-article

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.

Published by

European heart journal

Summary

journal-article

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.

Published by

European heart journal

Summary

journal-article

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.

Published by

European heart journal

Summary

journal-article

Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.

Published by

Journal of molecular and cellular cardiology

Summary

journal-article

Preclinical development of a miR-132 inhibitor for heart failure treatment.

Published by

Nature communications

Summary

journal-article

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury.

Published by

International journal of molecular sciences

Summary

journal-article

Structural and functional characterization of the Curli adaptor protein CsgF.

Published by

FEBS letters

Summary

journal-article

Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction.

Published by

Circulation research

Summary

journal-article

Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.

Published by

Circulation research

Summary

journal-article

Long Noncoding RNAs in Pathological Cardiac Remodeling.

Published by

Circulation research

Summary

journal-article

Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Published by

Physiological reviews

Summary

journal-article

Long noncoding RNA Chast promotes cardiac remodeling.

Published by

Science translational medicine

Summary

journal-article

Long noncoding RNAs as inducers and terminators of vascular development.

Published by

Circulation

Summary

journal-article

Bioinformatics of cardiovascular miRNA biology.

Published by

Journal of molecular and cellular cardiology

Summary

journal-article

Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model.

Published by

Experimental lung research

Summary

journal-article

Regulatory RNAs and paracrine networks in the heart.

Published by

Cardiovascular research

Summary

journal-article

Circulating microRNAs as potential biomarkers of aerobic exercise capacity.

Published by

American journal of physiology. Heart and circulatory physiology

Summary

journal-article